Related content

Empiric Oral Monotherapy for Hospitalized Patients with Community-Acquired Pneumonia: An Idea Whose Time Has Come

By Cunha B.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 23, Iss. 2, 2004-02 ,pp. : 78-81

Springer Publishing Company

Access to resources Recommend Favorite

Risk factors for levofloxacin-nonsusceptible Streptococcus pneumoniae in community-acquired pneumococcal pneumonia: a nested case–control study

By Kang C.-I.   Song J.-H.   Kim S.   Chung D.   Peck K.   So T.   Hsueh P.-R.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 33, Iss. 1, 2014-01 ,pp. : 55-59

Springer Publishing Company

Access to resources Recommend Favorite

Severe adenovirus community-acquired pneumonia mimicking Legionella

By Cunha B.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 28, Iss. 3, 2009-03 ,pp. : 313-315

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of sequential moxifloxacin for treatment of community-acquired pneumonia associated with atypical pathogens

By Hoeffken G.   Talan D.   Larsen L.   Peloquin S.   Choudhri S.   Haverstock D.   Jackson P.   Church D.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 23, Iss. 10, 2004-10 ,pp. : 772-775

Springer Publishing Company

Access to resources Recommend Favorite

Monotherapy versus combination antibiotic therapy for patients with bacteremic Streptococcus pneumoniae community-acquired pneumonia

By Chokshi R.   Restrepo M.   Weeratunge N.   Frei C.   Anzueto A.   Mortensen E.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 26, Iss. 7, 2007-07 ,pp. : 447-451

Springer Publishing Company

Access to resources Recommend Favorite